benchmark

How did you short them after hours? what broker offers this?

are you buying preferred or common?

"junkiest of tech ETFs" What are some example of these type of ETFs?

Rising yield might also push indicies higher https://www.forbes.com/sites/danrunkevicius/2021/03/04/rising-rates-are-great-for-the-stock-market-except-for-these-stocks/

Keep them coming, I've learned something from your posts.

Thanks. Looks like that the secondary offering in 2017 caused the stock to drop from $23 to ~$20?

Thanks Wabuffo and Infeisone. This is helpful. Where was the last time that they did the secondary offer? Infeisone, I also own WMB, and am considering trimming as well fwiw

is $20 your target price to unload? Given it's still paying 10%+ dividend, why not just keep it to continue to collect the divs...

Time to buy gold?

Fair enough, though I do want them to start with some solid understanding of investing -- maybe it's my bias, but I would not want them to buy TSLA or Gamestop just because everyone else is buying.

1) what's an easy to follow investment book that you'd recommend? 2) what are 1-3 stocks that one can do some analysis on? (i.e., not too complicated) Goal: 1) have them learn investing; 2) use the learning to analyze some stocks as practice and hopefully invest. thanks.

What would you expect that bounce would be after the BK exit?

at these level? curious about your thesis.

When was DJCO's purchase?

Why selling it now? there should still be some room to run.

Interesting, what's the best way to track/play 'gold'?

it's still has a 8.23% yield at the current price. W/o doing anything, it's not a shabby return.

Thank you Wabuffo. I have some questions regarding the timeline of this, especially with the long tail mentioned in the doc: • principal and interest payments due under a credit agreement entered into by the Company, as a lender, with CareView Communications, Inc., the recoverable amount of which is expected to be substantially less than the principal and interest payable; • amounts received in connection with our agreement with a counterparty pursuant to which we sold the remaining assets of DFM, LLC, to which we are entitled to a single-digit percentage of any net final award in connection with its monetization process using certain intangible assets included in the sale; • amounts received from a royalty based on a “know-how” license for technology provided in the design of solanezumab, an Eli Lilly-licensed humanized monoclonal antibody being tested in a study of older individuals who may be at risk of memory loss and cognitive decline due to Alzheimer’s disease. The 2% royalty on net sales is payable for 12.5 years after the product’s first commercial sale, and is currently in ongoing clinical studies with Phase 3 testing results expected in July of 2022; If they distribute the cash say by end of 2020, but receives royalty payment later. Is the shareholders supposed to track this themselves for tax purpose? How are these treated? Overall, what's your eval of the potential payment and timeline? thanks much.

Wow, have you noticed changes in your body/health?

What's the PDLI liquidation play? simple google didn't yield anything

why KNOP? Quick trade (went long two months ago I think), never intended to hold for long but liked the somewhat uncorrelated risk of their charters and their niche . I think it'll do fine and trade up to BV, but I went a bit on margin in March and I'm dialing back down as well as putting more money into markets outside of the US. Makes sense. Given that it's still yielding 10+% dividend, assuming that your margin rate is not high, might worth the wait til it runs to BV.

why KNOP?

One thing that's alarming is that he seems to think that the death rate is really 1-2%. I always thought that there are lots of unreported cases... :(